Newsletter

Multiple Myeloma
A variety of new drugs and Multiple myeloma market: What will be the market landscape in the next decade?
Multiple Myeloma Newsletter

More Whitepapers / Newsletters

Cancer Globally (Vol. 1, Issue 1)
Cancer Globally (Vol. 1, Issue...

There are about 200 different types of cancer, making it one of the most diverse types of indication, afflicting almost all parts of the body. Cancer has a maximum prevalence in Africa, Asia, and Cent...

HIV-Associated Lipodystrophy Market
HIV-Associated Lipodystrophy

HIV-associated lipodystrophy (HAL), is a condition characterized by the redistribution of adipose tissue. It can be due to several reasons, however, a significant amount of research done links its cau...

Warm Autoimmune Hemolytic Anemia
Warm Autoimmune Hemolytic Anem...

Autoimmune hemolytic anemia (AIHA) is a rare acquired autoimmune disease. It is caused by the dysfunction in the immune system in which the immune system attacks its red blood cells considering them f...

Generalized Myasthenia Gravis Newsletter
Generalized Myasthenia Gravis

Myasthenia Gravis is a chronic autoimmune neuromuscular disease responsible for weakness in the skeletal muscles, including the muscles of arms and legs, leading to breathing difficulty and mobility i...

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required for the break-down of glucocerebroside thus causing a build-up in ar...